Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen A Rappaport

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Provider (Washington, D.C.)|January 22, 2004
Osteoporosis: silent no moreStephen A Rappaport, Jan Kennedy
Journal of the American Medical Directors Association|December 30, 2008
A randomized, double-blind, placebo-controlled tolerability study of intramuscular aripiprazole in acutely agitated patients with Alzheimer's, vascular, or mixed dementiaStephen A Rappaport, Ronald N Marcus, George Manos, et al.
Clinical Therapeutics|October 3, 2015
Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extension TrialRobert Buynak, Stephen A Rappaport, Kevin Rod, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 9, 2005
Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementiaWalter G Deberdt, Maurice W Dysken, Stephen A Rappaport, et al.
Alzheimer'S Research & Therapy|November 28, 2013
The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's diseaseRaj C Shah, Patrick J Kamphuis, Sue Leurgans, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Provider (Washington, D.C.)|January 22, 2004
Osteoporosis: silent no moreStephen A Rappaport, Jan Kennedy
Journal of the American Medical Directors Association|December 30, 2008
A randomized, double-blind, placebo-controlled tolerability study of intramuscular aripiprazole in acutely agitated patients with Alzheimer's, vascular, or mixed dementiaStephen A Rappaport, Ronald N Marcus, George Manos, et al.
Clinical Therapeutics|October 3, 2015
Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extension TrialRobert Buynak, Stephen A Rappaport, Kevin Rod, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 9, 2005
Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementiaWalter G Deberdt, Maurice W Dysken, Stephen A Rappaport, et al.
Alzheimer'S Research & Therapy|November 28, 2013
The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's diseaseRaj C Shah, Patrick J Kamphuis, Sue Leurgans, et al.
Pageof 1